Clinical Trials | September 23, 2025
Tegoprazan, a novel patented molecule indicated for acid-related gastrointestinal diseases, is launched in India under the brand name PCAB
Biocon Foundation is also expanding its reach with this first initiative in Channapatna region
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
The partnership will create a first-of-its-kind, fully integrated offering for the development of mRNA drug products
The study showed a significant 29% reduction in the risk for heart attack, stroke and death from any cause in the Wegovy users
Treatment with Verzenio also resulted in sustained invasive disease-free survival and distant relapse-free survival benefit
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
The patient had been battling DFSP for over eight years, enduring multiple recurrences despite three previous surgeries
Subscribe To Our Newsletter & Stay Updated
